Download presentation
Presentation is loading. Please wait.
Published byAubrie Anthony Modified over 6 years ago
1
Integrating Hepatitis C Treatment in Primary Care
D Swan, G McCombe, E O’Connor, C Murphy, G Avramovic, J Macias, J Surey, C Oprea, P Vickerman, Z Ward, JS Lambert, W Cullen School of Medicine, University College Dublin, Ireland 1
2
Acknowledgements Co-funded by European Commission through its EU Third Health Programme and Ireland’s Health Services Executive Participating GPs and patients Our partners: UCL, U Bristol, SAS Seville Website: 2
3
Aims To describe integrated model of HCV care and its implementation in practice To examine current HCV care practice Website: 3
4
Aims To describe integrated model of HCV care and its implementation in practice To examine current HCV care practice Website: 4
7
A Family Doctor in Dublin…
“Between April 1980 and April 1985, a 2-3 doctor practice in Dolphin’s Barn with 3000 patients identified 67 patients who had injected heroin. Mostly male, poor, living in local authority housing and had spent time in prison…42 from families with alcohol / drug abuse…56 children…” O'Kelly, O'Doherty et al., Ir Med J, 1986 And it was a family physician, Fergus O’Kelly, who published the first reports of this problem and documented its high prevalence among young men and association with social disadvantage…interestingly, they also highlighted the transgenerational nature of the issue… 7
8
O'Kelly, O'Doherty et al., Ir Med J, 1986
9
“we see it in the faces and stories of our patients”
Does primary care have a role? “we see it in the faces and stories of our patients”
10
Introduction Though HCV common among PWIDs attending primary care, complex barriers mean few have been treated HCV infection treatment in primary care now feasible, acceptable…. In Ireland and the EU, primary care is increasingly providing long-term care for people who inject drugs Arora et al, NEJM, 2011; Swan et al, AIDS Patient Care and STDs, 2010; Cullen et al, BJGP, 2006. 10
11
Advise on safe drug use, transmission
Assess HCV status Advise on safe drug use, transmission Assess other bloodborne viruses too Refer to clinic for evaluation / treatment Address lifestyle / psychosocial issues Immunise (HBV, HAV) Provide ongoing psychosocial support Review / monitor for liver disease Provide continuing, holistic care Barry et al, IJMS, 2004 & HSE Hepatitis C Strategy, 2014 Cullen et al, Ir J Med Sci, 2004
12
Heplink Objectives To improve HCV care outcomes among patients receiving OST in general practice, by: - developing integrated model of HCV care - evaluating feasibility, acceptability and likely efficacy 13
13
Hepatitis C Integrated care model
Education of community practitioners Outreach of HCV trained nurse into GP practices Enhanced access to community-based HCV evaluation (including fibroscan) 14
14
Recruitment & Data collection
GP practices eligible if: OST prescribing Catchment area of MMUH Patients eligible if: ≥ 18 years of age on OST attend the practice for any reason during the recruitment period 15
15
GP Practices recruited n=14
Patients recruited n=135 Baseline data on HCV care processes / outcomes extracted from the clinical records of participating patients 16
16
10.5% initiated HCV treatment 10.5% initiated HCV treatment
92.5% screened for HCV 71.4% HCV antibody positive 55.6% referred to secondary care 47.4% attended secondary care 10.5% initiated HCV treatment 92.5% screened for HCV 71.4% HCV antibody positive 55.6% referred to secondary care 47.4% attended secondary care 10.5% initiated HCV treatment
17
Intervention Academic detailing, education HCV Ab status: Known
Nurse consultation Explain role, assessment, referral procedures Checks participant’s HCV Ab and risk status HCV Ab status: Unknown Nurse arranges HCV testing HCV Ab status: Known
18
Intervention HCV Ab negative HCV Ab positive Addiction assessment
Info/Education Arrange re-testing Handover to GP Check PCR status PCR neg PCR pos/UK Addiction assessment Fibroscan Facilitate RNA testing Information/Education GP handover
19
HCV Ab+ and Ag/RNA positive / unknown
REFERRAL CRITERIA: HCV Ab+ and Ag/RNA positive / unknown Intervention Referral to Hepatology/ID Liaison between GP/patient and hospital clinic
20
Process of care 100 Nurse assessments
The integrated model of HCV care has been piloted in 14 practices 100 Nurse assessments 45 HCV Ab+ patients had fibroscan 21/45 (46.7%) scored ≥8.5 kPa 13/45 (28.9%) were cirrhotic, i.e. scored > 12.5 kPa 21
21
Practice & policy Ireland East Hospital Group HSE Clinical Programmes
Consultation
22
…and beyond
23
(SVB and Rahova prison)
…and beyond DUBLIN LONDON BUCHAREST SEVILLE TOTAL TARGET No. of GP practices/clinical sites recruited 14 1 9 3 27 24 No. of patients recruited 135 39 169 109 452 240 No. of patients on whom baseline data has been collected 134 96 438 No. of GP practices/clinical sites received HCV education/academic detailing 35 53 No. of GP practices/clinical sites received nurse specialist liaison 18 No. of GP practices/clinical sites received enhanced specialist assessment (incl. fibroscan) 2 (SVB and Rahova prison) 20
24
Discussion Recruitment and baseline data collection complete / targets achieved Most screened, access to specialist assessment / treatment a challenge (47% and 15% respectively) Intervention ongoing especially in other sites, evaluation pending 29% of HCV Ab+ participants fibro-scanned had cirrhosis Research into practice and policy… 25
25
Integrated Care ‘…a worldwide trend in health care reforms focusing on more coordinated forms of care provision…may be seen as a response to the fragmented delivery of health and social services … in many health systems WHO gives the following definition: "a concept bringing together inputs, delivery, management and organization of services related to diagnosis, treatment, care, rehabilitation and health promotion. Integration is a means to improve services in relation to access, quality, user satisfaction and efficiency”’ 26
26
Thank you Email: Walter.cullen@ucd.ie
Website: 27
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.